In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

A local vascular surgeon has highlighted a simple injection that could alleviate leg pain for those experiencing heaviness or ...

Eli Lilly investors and analysts said they want to hear details from the company on how exactly it plans to grow U.S. sales ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

According to their findings, semaglutide led to a "significant" reduction in overall heart weight, cardiomyocyte area, and ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

ATLANTA (AP) — A new leg kick helped make Jurickson Profar a first-time All-Star at 31 with San Diego. That important tweak to his swing also helped lead Profar to Atlanta. Atlanta Braves ...

Eli Lilly and Co. reported that its FDA-approved weight-loss drug Zepbound (tirzepatide) outperformed Novo Nordisk A/S’s Wegovy (semaglutide) in the phase IIIb Surmount-5 trial.

Available Ozempic alternatives: Mounjaro, Victoza, Metformin, Saxenda, Wegovy, Trulicity, Rybelsus, and Zepbound Keep in mind ... However, unlike Ozempic, you inject Victoza once per day rather ...

Oprah Winfrey says taking a GLP-1 drug such as Ozempic and Wegovy has changed her entire perspective on “thin people.” A Type 2 diabetes medication that can also aid in weight loss, GLP-1 ...

Today, GLP-1 drugs, including Wegovy, Mounjaro and Zepbound, have become household names and key tools in the fight against obesity: 1 in 8 American adults say they have used a GLP-1 drug ...